Lincomycin Hydrochloride Price Trend and Forecast

Lincomycin Hydrochloride Regional Price Overview

Get the latest insights on price movement and trend analysis of Lincomycin Hydrochloride in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Lincomycin Hydrochloride Price Trend for the Q3 of 2024

Lincomycin hydrochloride is a commonly used drug that is generally employed to treat bacterial infections, particularly those caused by anaerobic bacteria and certain Gram-positive bacteria, all around the world. Being an antibiotic drug, the prices of lincomycin hydrochloride are highly regulated by domestic pharma and drug norms and regulations in different countries. So, during the third quarter, the prices of lincomycin hydrochloride remained consolidated within the very close range.
 

Lincomycin Hydrochloride Price Chart

Please Login or Subscribe to Access the Lincomycin Hydrochloride Price Chart Data
 

The prices did show regional variations depending on the macroeconomics and supply constraints of the regions, but the prices maintained an overall steady trajectory.

Apart from this, the Health Ministry of India banned 156 fixed-dose combination drugs. The action was taken as a follow-up to recommendations from an expert committee and the Drug Technical Advisory Board (DTAB). The banned FDCs lacked therapeutic justification and posed more harm than benefit to patients.

Overall, the prices of lincomycin hydrochloride presented a stable market trend influenced by tighter government policies on safety concerns. Lincomycin hydrochloride was not on the list, however, the highly regulated and dynamic nature of pharma sector became evident.

Analyst Insight

According to Procurement Resource, the prices of lincomycin hydrochloride are expected to remain stable without many fluctuations in the upcoming quarter as well; not much change in the current pricing dynamics is expected.
 

Lincomycin Hydrochloride Price Trend for the Q2 of 2024

Lincomycin Hydrochloride is used to treat a variety of bacterial infections, particularly those caused by Gram-positive bacteria, including Staphylococcus, Streptococcus, and Pneumococcusspecies. During the second quarter of 2024, Lincomycin Hydrochloride prices were mostly consolidated and confined within very close ranges despite the scope of fluctuation in upstream and downstream outlooks. This is primarily because of the highly regulated nature of the pharma industry.

The Indian government has reduced the prices of 41 commonly used medicines and six formulations for conditions like cardiovascular diseases, diabetes, and other ailments. This decision, announced by the Department of Pharmaceutical and the National Pharmaceutical Pricing Authority (NPPA), covers drugs for diabetes, pain relief, cardiovascular conditions, liver issues, antacids, infections, allergies, multivitamins, and antibiotics.

In Europe, the supply chains among the member nations remained a bigger problem. Heavy stocking in some countries created supply problems in others, ahead of the E.U. Health Council meeting on June’21, a coalition of six E.U. member states—Czechia, Cyprus, Malta, Romania, Slovakia, and Slovenia brought it up. Overall, mixed market sentiments were observed.

Analyst Insight

According to Procurement Resource, not much change is anticipated in the Lincomycin Hydrochloride prices going forward in the coming months as well.
 

Lincomycin Hydrochloride Price Trend for the Q1 of 2024

Asia

Lincomycin hydrochloride is a popular drug usually employed in the treatment procedures of bacterial infections around the globe. Since the advent of the new year, the lincomycin hydrochloride price trend has been driven by the complex interplay of the rising cost of feedstock chemicals and the surging imbalance of supply and demand sectors of the market.

The persistent challenges in acquiring the commodity amid the slowdown of the production sector due to the onset of the Chinese New Year holiday season and spring festivities widened the gap between the supply and demand sectors of the market, favoring an uptrend in the prices of lincomycin hydrochloride. The elevation in the procurement rates was further fueled by the ease in the inflationary pressure on the consumers. Therefore, the cumulative effect of these changing factors led to a gradual and slow rise in the pricing patterns of lincomycin hydrochloride.

Europe

The consequences of the slowdown in the momentum of the Chinese market were not only limited to the Asian countries, as Europe also struggled with the depleting level of inventories during the first quarter of 2024. The consumer demand for the commodity was only moderate, and even the production volumes remained meek throughout the aforementioned phase.

Along with the loss of Chinese imports, the rising number of attacks on shipments by Houthi communities through the Red Sea route because of the ongoing Israel-Hamas crisis further had an adverse effect on inventory levels. In domestic production, the surge in crude oil and feedstock chemical prices concerned the manufacturers amid only mild rates of procurement from the downstream industries, pushing them to lower their production volumes and leading to a slight rise in the prices of lincomycin hydrochloride.

North America

The disruptions in the global supply chain, particularly due to the Suez Canal disruptions, led to increased shipping and operational costs, prompting manufacturers and traders to raise prices to maintain profitability, altering the price trajectory of lincomycin hydrochloride in North America. Further, the announcement of a surge in the prices of some specified drugs by the pharmaceutical giants in response to the government’s price capping on high-cost medications additionally favored the surge in the price trend of lincomycin hydrochloride. This avalanche and constant price bidding between the pharma companies and the US government triggered a broader reevaluation of pricing strategies among suppliers and manufacturers worldwide, translating its effect on the pricing trajectory of lincomycin hydrochloride.

Analyst Insight

According to Procurement Resource, the price trend of Lincomycin Hydrochloride is expected to surge in the forthcoming quarter with the rise in the prices of subsidiary medications by pharmaceutical companies in order to sustain their profitability.
 

Lincomycin Hydrochloride Price Trend for the October - December of 2023

Lincomycin Hydrochloride is a commonly prescribed antibiotic drug that is derived from the fermentation process of Algae Streptomyces lincolnnsis and is used in both human and veterinary medicine to treat various bacterial infections. The Supreme Court of India asked the Indian Government to present its measures for controlling the essential and life-saving medicine prices as the medical inflation reached a staggering 14%, which far exceeded the economic inflation in the country, which was around 5% during that time.

These shocking figures are bound to affect the most vulnerable sections of the population. In response, India's National Pharmaceutical Pricing Authority (NPPA) has brought 33 fixed-dose combination drugs under regulation, ensuring affordability. Also, the NPPA has set retail prices for 19 drugs starting January 1, 2024. The rates applicable to medications for fever, pain, and infections do not include the Goods and Services Tax (GST), as per an official notification.

Analyst Insight

According to Procurement Resource, the Lincomycin Hydrochloride prices are likely to fluctuate along similar lines in the coming quarter given the current regulations and efforts to affordability.
 

Lincomycin Hydrochloride Price Trend for July - September of 2023

Lincomycin hydrochloride is an antibiotic used in many different industrial processes. It is mostly used in pharmaceuticals to make antibiotics, which are used to fight bacterial infections. In biotechnology research, lincomycin hydrochloride is also used in the culture of cell cultures.

In India, the market of antibiotics such as lincomycin hydrochloride experienced a significant downfall in the third quarter of 2023. The production rates of lincomycin hydrochloride surged during this phase, while its demand from the end-user industries slid remarkably and thus hampered the growth of lincomycin hydrochloride and the overall pharmaceutical market.

Analyst Insight

According to Procurement Resource, the price of Lincomycin Hydrochloride is estimated to struggle with the fluctuating sentiments shown by the pharmaceutical sector.
 

Lincomycin Hydrochloride Price Trend for First Half of 2023

The price trend for lincomycin hydrochloride were dependent on the performance of the antibacterial medicines market. The first quarter of 2023 witnessed fluctuating market sentiments. However, in the second quarter, the prices of medicines in India rose by 12% from April, further hurting the spending sentiments of consumers.

This rise in the prices was the direct consequence of an increase in the cost of production in India, along with enhanced prices of raw materials. The majority of feedstock materials are imported from China, and restrictions imposed by the government on imports from China increased the cost of feedstock materials required for the production of lincomycin hydrochloride, thus resulting in a rise in its price trend.

Analyst Insight

According to Procurement Resource, the price of Lincomycin hydrochloride is expected to oscillate in the upcoming months as the increasing cost of raw materials and high uncertainties in the pharmaceutical markets are estimated to affect the lincomycin hydrochloride market negatively.

Procurement Resource provides latest prices of Lincomycin Hydrochloride. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.